Truist Maintains Buy Rating on Exponent (EXPO) While Cutting Price Target to $90
On November 2, Truist lowered its price target for Exponent, Inc. (NASDAQ:EXPO) from $100 to $90 while maintaining a Buy rating, according to a report by The Fly.
Exponent Inc (EXPO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Point72 Asset Management Steve Cohen | 471,025 | $32,726,831 | 0.05% | |
| 2. | Royce & Associates Chuck Royce | 375,220 | $26,070,286 | +34% | 0.26% |
| 3. | Two Sigma Advisors John Overdeck And David Siegel | 329,800 | $22,914,504 | 0.05% | |
| 4. | Citadel Investment Group Ken Griffin | 286,043 | $19,874,268 | +58% | 0% |
| 5. | D E Shaw D. E. Shaw | 283,825 | $19,720,161 | +35% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $107.59 | 31 | $3,335.21 | 224,350 | 2024-09-27 | Filing | |
| $90.36 | 113 | $10,211.13 | 294,075 | 2024-06-28 | Filing | |
| $78.56 | 146 | $11,469.10 | 293,962 | 2024-03-29 | Filing | |
| $84.46 | 61 | $5,152.33 | 28,632 | 2025-01-03 | Filing | |
| $107.59 | 45 | $4,841.44 | 28,571 | 2024-09-27 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $70.74 | 1,675 | $118,487.32 | 84,134 | 2025-11-17 | Filing | |
| $70.21 | 3,225 | $226,411.13 | 83,429 | 2025-11-17 | Filing | |
| $66.79 | 1,704 | $113,814.59 | 83,429 | 2025-10-15 | Filing | |
| $66.84 | 3,226 | $215,625.84 | 82,753 | 2025-10-15 | Filing | |
| $69.77 | 3,226 | $225,069.31 | 82,753 | 2025-09-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,068,636 | $421,648,862 | 0.01% | |
| 2. | 5,250,753 | $364,822,319 | 0.01% | |
| 3. | 4,489,747 | $311,947,673 | 0.76% | |
| 4. | 2,361,196 | $164,055,867 | 2.63% | |
| 5. | 1,858,685 | $129,141,465 | 2.21% |
News See All
15 Overlooked Dividend Stocks to Buy Right Now
A report by Thornburg Investment Management noted that, unlike bond interest payments that stay fixed for the bond’s duration, cash dividends paid to equity shareholders can grow over time.
Exponent, Inc. (NASDAQ:EXPO) Q3 2025 Earnings Call Transcript
Operator: Good day, and welcome to the Exponent, Inc. Third Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded.
Exponent (EXPO) Tumbled as Guidance Fell Short of Expectations
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” second-quarter 2025 investor letter.
What Makes Exponent (EXPO) a Compelling Short Opportunity?
Prosper Stars & Stripes, a long/short equity fund, recently released its second quarter 2025 investor letter. A copy of the letter can be downloaded here.
Exponent, Inc. (NASDAQ:EXPO) Q2 2025 Earnings Call Transcript
Operator: Good day, and welcome to Exponent Second Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded.
Should You Hold Exponent (EXPO) for the Long Term?
Conestoga Capital Advisors, an asset management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Exponent, Inc. (EXPO): A Bull Case Theory
We came across a bullish thesis on Exponent, Inc. on FluentInQuality’s Substack. In this article, we will summarize the bull’s thesis on EXPO.
Exponent, Inc. (NASDAQ:EXPO) Q1 2025 Earnings Call Transcript
Operator: Good day and welcome to the Exponent, Inc. First Quarter 2025 Earnings Conference Call. All participants will be in the listen-only mode.
10 Overlooked Dividend Stocks to Buy Now
In recent times, dividend investing—also known as equity income—has fallen out of favor. Once a widely followed and dependable strategy, it has gradually been overshadowed.
Hedge Fund Resource Center Billionaire Hedge Funds
